Interleukin-2 (IL-2) After Autologous Bone Marrow Transplantation (BMT):A Pilot Study of Late Administration, 2–3 Months Post ABMT View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1990

AUTHORS

D. Maraninchi , D. Blaise , D. Olive , M. Attal , M. H. Gaspard , D. Boule , C. Jasmin , C. Pourreau , P. Palmer , S. Négrier , I. Philip

ABSTRACT

Association of high-dose radiotherapy ± chemotherapy can cure poor risk hematological neoplasias and solid tumors. This cure is related to the treatment dose effect as well as to the immunological effect (graft versus tumor effect) demonstrated after bone marrow transplant (BMT). Relapses are less frequent after allogeneic BMT than after autologous or syngeneic transplant; they are also less frequent following graft-versus-host disease (GVHD) in allogeneic transplantation (graft versus leukemia (GVL) effect). T cell depletion increases the risk of relapses [2]. The use of recombinant interleukine-2 (rIL-2) is under intensive investigation since promising reports have shown high activity in patients with refractory neoplasias [3]. T lymphocytes with antileukemic activity can be expanded from the blood of patients with leukemia [1]. Use of rIL-2 after autologous transplant may enhance immunologic abnormalities already documented e.g., CD4()CD8 inversion, increase in activated T cells and natural killer (NK) cells, and by this way increase antitumoral activated. This study is a phase 1 study to detemine feasability of rIL-2 administration 60-90 days post-autologous BMT. More... »

PAGES

691-697

Book

TITLE

Cytokines in Hemopoiesis, Oncology, and AIDS

ISBN

978-3-540-52281-2
978-3-642-75510-1

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-75510-1_87

DOI

http://dx.doi.org/10.1007/978-3-642-75510-1_87

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021751869


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Maraninchi", 
        "givenName": "D.", 
        "id": "sg:person.01364057057.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364057057.31"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Blaise", 
        "givenName": "D.", 
        "id": "sg:person.0644473065.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644473065.59"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Olive", 
        "givenName": "D.", 
        "id": "sg:person.0622550070.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622550070.07"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Attal", 
        "givenName": "M.", 
        "id": "sg:person.01355527565.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355527565.13"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Gaspard", 
        "givenName": "M. H.", 
        "id": "sg:person.0634547675.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634547675.86"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Boule", 
        "givenName": "D.", 
        "type": "Person"
      }, 
      {
        "familyName": "Jasmin", 
        "givenName": "C.", 
        "id": "sg:person.01120567767.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120567767.26"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Pourreau", 
        "givenName": "C.", 
        "id": "sg:person.01134434522.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134434522.91"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Palmer", 
        "givenName": "P.", 
        "id": "sg:person.01345034754.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345034754.91"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "N\u00e9grier", 
        "givenName": "S.", 
        "id": "sg:person.0723756046.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723756046.31"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Philip", 
        "givenName": "I.", 
        "id": "sg:person.0725534606.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725534606.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm198512053132327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000718956"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1990", 
    "datePublishedReg": "1990-01-01", 
    "description": "Association of high-dose radiotherapy \u00b1 chemotherapy can cure poor risk hematological neoplasias and solid tumors. This cure is related to the treatment dose effect as well as to the immunological effect (graft versus tumor effect) demonstrated after bone marrow transplant (BMT). Relapses are less frequent after allogeneic BMT than after autologous or syngeneic transplant; they are also less frequent following graft-versus-host disease (GVHD) in allogeneic transplantation (graft versus leukemia (GVL) effect). T cell depletion increases the risk of relapses [2]. The use of recombinant interleukine-2 (rIL-2) is under intensive investigation since promising reports have shown high activity in patients with refractory neoplasias [3]. T lymphocytes with antileukemic activity can be expanded from the blood of patients with leukemia [1]. Use of rIL-2 after autologous transplant may enhance immunologic abnormalities already documented e.g., CD4()CD8 inversion, increase in activated T cells and natural killer (NK) cells, and by this way increase antitumoral activated. This study is a phase 1 study to detemine feasability of rIL-2 administration 60-90 days post-autologous BMT.", 
    "editor": [
      {
        "familyName": "Freund", 
        "givenName": "Mathias", 
        "type": "Person"
      }, 
      {
        "familyName": "Link", 
        "givenName": "Hartmut", 
        "type": "Person"
      }, 
      {
        "familyName": "Welte", 
        "givenName": "Karl", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-75510-1_87", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-540-52281-2", 
        "978-3-642-75510-1"
      ], 
      "name": "Cytokines in Hemopoiesis, Oncology, and AIDS", 
      "type": "Book"
    }, 
    "name": "Interleukin-2 (IL-2) After Autologous Bone Marrow Transplantation (BMT):A Pilot Study of Late Administration, 2\u20133 Months Post ABMT", 
    "pagination": "691-697", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-75510-1_87"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "67a277f2eb0cd0117f6adb03cf8d5ff2af832bef938b35e8fc55de16a5b3da85"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021751869"
        ]
      }
    ], 
    "publisher": {
      "location": "Berlin, Heidelberg", 
      "name": "Springer Berlin Heidelberg", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-75510-1_87", 
      "https://app.dimensions.ai/details/publication/pub.1021751869"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T00:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000256.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-3-642-75510-1_87"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75510-1_87'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75510-1_87'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75510-1_87'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75510-1_87'


 

This table displays all metadata directly associated to this object as RDF triples.

133 TRIPLES      23 PREDICATES      28 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-75510-1_87 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Nc3f1b988bc764e4cbb483ed8b800a9dc
4 schema:citation https://doi.org/10.1056/nejm198512053132327
5 schema:datePublished 1990
6 schema:datePublishedReg 1990-01-01
7 schema:description Association of high-dose radiotherapy ± chemotherapy can cure poor risk hematological neoplasias and solid tumors. This cure is related to the treatment dose effect as well as to the immunological effect (graft versus tumor effect) demonstrated after bone marrow transplant (BMT). Relapses are less frequent after allogeneic BMT than after autologous or syngeneic transplant; they are also less frequent following graft-versus-host disease (GVHD) in allogeneic transplantation (graft versus leukemia (GVL) effect). T cell depletion increases the risk of relapses [2]. The use of recombinant interleukine-2 (rIL-2) is under intensive investigation since promising reports have shown high activity in patients with refractory neoplasias [3]. T lymphocytes with antileukemic activity can be expanded from the blood of patients with leukemia [1]. Use of rIL-2 after autologous transplant may enhance immunologic abnormalities already documented e.g., CD4()CD8 inversion, increase in activated T cells and natural killer (NK) cells, and by this way increase antitumoral activated. This study is a phase 1 study to detemine feasability of rIL-2 administration 60-90 days post-autologous BMT.
8 schema:editor N3e0127fac1454e0abce4920ffd4c8d81
9 schema:genre chapter
10 schema:inLanguage en
11 schema:isAccessibleForFree false
12 schema:isPartOf N04b45c39b33c4d75bb61bc6c49a3ee3c
13 schema:name Interleukin-2 (IL-2) After Autologous Bone Marrow Transplantation (BMT):A Pilot Study of Late Administration, 2–3 Months Post ABMT
14 schema:pagination 691-697
15 schema:productId N211c9325a01c426d9f70c4b660eae74e
16 N43fc8ef3c16647cb812818724142dd2b
17 N68ba27bd7ad14a09963ab03e173f1ee0
18 schema:publisher N54619aa32a254d44879f206f64384c29
19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021751869
20 https://doi.org/10.1007/978-3-642-75510-1_87
21 schema:sdDatePublished 2019-04-16T00:48
22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
23 schema:sdPublisher N234a0ff739b54440afbe5a1e197d64b9
24 schema:url http://link.springer.com/10.1007/978-3-642-75510-1_87
25 sgo:license sg:explorer/license/
26 sgo:sdDataset chapters
27 rdf:type schema:Chapter
28 N04b45c39b33c4d75bb61bc6c49a3ee3c schema:isbn 978-3-540-52281-2
29 978-3-642-75510-1
30 schema:name Cytokines in Hemopoiesis, Oncology, and AIDS
31 rdf:type schema:Book
32 N0979db0c62a94caf8303c707cc237f99 schema:familyName Boule
33 schema:givenName D.
34 rdf:type schema:Person
35 N1cbb1789632347d994d74acadb18a27e rdf:first sg:person.01134434522.91
36 rdf:rest N733bdb653e174127b481bd215d206b66
37 N211c9325a01c426d9f70c4b660eae74e schema:name doi
38 schema:value 10.1007/978-3-642-75510-1_87
39 rdf:type schema:PropertyValue
40 N234a0ff739b54440afbe5a1e197d64b9 schema:name Springer Nature - SN SciGraph project
41 rdf:type schema:Organization
42 N31274331c7f84540b29fb0edf43beab5 rdf:first sg:person.0725534606.74
43 rdf:rest rdf:nil
44 N3350ca8a150f4a4b9efa199629444a2c schema:familyName Freund
45 schema:givenName Mathias
46 rdf:type schema:Person
47 N343af3879c674286961b97b5593e11e5 rdf:first sg:person.01355527565.13
48 rdf:rest N42b5df3c20704506a0b2358884f2a1ec
49 N3e0127fac1454e0abce4920ffd4c8d81 rdf:first N3350ca8a150f4a4b9efa199629444a2c
50 rdf:rest N4012f51c1af24549ba16cf38ccf4427f
51 N4012f51c1af24549ba16cf38ccf4427f rdf:first Na9361821bfe94df896a711b5245232bf
52 rdf:rest N8a2ca57b55bb44b5a4c4bec04ad5d3a5
53 N4269623a424548b59412cebba6dfdf72 schema:familyName Welte
54 schema:givenName Karl
55 rdf:type schema:Person
56 N42b5df3c20704506a0b2358884f2a1ec rdf:first sg:person.0634547675.86
57 rdf:rest N52a737bd3d6b4ac587bc3c8c58036007
58 N43fc8ef3c16647cb812818724142dd2b schema:name readcube_id
59 schema:value 67a277f2eb0cd0117f6adb03cf8d5ff2af832bef938b35e8fc55de16a5b3da85
60 rdf:type schema:PropertyValue
61 N4729315fe030436b9b86fe66cb8a39fd rdf:first sg:person.0723756046.31
62 rdf:rest N31274331c7f84540b29fb0edf43beab5
63 N52a737bd3d6b4ac587bc3c8c58036007 rdf:first N0979db0c62a94caf8303c707cc237f99
64 rdf:rest Nbc7200967144434aba706fbe4a20eea0
65 N54619aa32a254d44879f206f64384c29 schema:location Berlin, Heidelberg
66 schema:name Springer Berlin Heidelberg
67 rdf:type schema:Organisation
68 N59a29470d48443aaadad665859a3bf68 rdf:first sg:person.0644473065.59
69 rdf:rest N64e687083ad44cad86db1a6db99f6e91
70 N64e687083ad44cad86db1a6db99f6e91 rdf:first sg:person.0622550070.07
71 rdf:rest N343af3879c674286961b97b5593e11e5
72 N68ba27bd7ad14a09963ab03e173f1ee0 schema:name dimensions_id
73 schema:value pub.1021751869
74 rdf:type schema:PropertyValue
75 N733bdb653e174127b481bd215d206b66 rdf:first sg:person.01345034754.91
76 rdf:rest N4729315fe030436b9b86fe66cb8a39fd
77 N8a2ca57b55bb44b5a4c4bec04ad5d3a5 rdf:first N4269623a424548b59412cebba6dfdf72
78 rdf:rest rdf:nil
79 Na9361821bfe94df896a711b5245232bf schema:familyName Link
80 schema:givenName Hartmut
81 rdf:type schema:Person
82 Nbc7200967144434aba706fbe4a20eea0 rdf:first sg:person.01120567767.26
83 rdf:rest N1cbb1789632347d994d74acadb18a27e
84 Nc3f1b988bc764e4cbb483ed8b800a9dc rdf:first sg:person.01364057057.31
85 rdf:rest N59a29470d48443aaadad665859a3bf68
86 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
87 schema:name Medical and Health Sciences
88 rdf:type schema:DefinedTerm
89 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
90 schema:name Immunology
91 rdf:type schema:DefinedTerm
92 sg:person.01120567767.26 schema:familyName Jasmin
93 schema:givenName C.
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120567767.26
95 rdf:type schema:Person
96 sg:person.01134434522.91 schema:familyName Pourreau
97 schema:givenName C.
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134434522.91
99 rdf:type schema:Person
100 sg:person.01345034754.91 schema:familyName Palmer
101 schema:givenName P.
102 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345034754.91
103 rdf:type schema:Person
104 sg:person.01355527565.13 schema:familyName Attal
105 schema:givenName M.
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355527565.13
107 rdf:type schema:Person
108 sg:person.01364057057.31 schema:familyName Maraninchi
109 schema:givenName D.
110 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364057057.31
111 rdf:type schema:Person
112 sg:person.0622550070.07 schema:familyName Olive
113 schema:givenName D.
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622550070.07
115 rdf:type schema:Person
116 sg:person.0634547675.86 schema:familyName Gaspard
117 schema:givenName M. H.
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634547675.86
119 rdf:type schema:Person
120 sg:person.0644473065.59 schema:familyName Blaise
121 schema:givenName D.
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644473065.59
123 rdf:type schema:Person
124 sg:person.0723756046.31 schema:familyName Négrier
125 schema:givenName S.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723756046.31
127 rdf:type schema:Person
128 sg:person.0725534606.74 schema:familyName Philip
129 schema:givenName I.
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725534606.74
131 rdf:type schema:Person
132 https://doi.org/10.1056/nejm198512053132327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000718956
133 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...